zepbound eli lilly - Search News

News

Eli Lilly sues Mochi Health and others

CNBC on MSN · 3d

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

UPI on MSN · 3d

Eli Lilly sues telehealth companies for selling Mounjaro, Zepbound compounds

Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs.

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

1d

Analysts Maintain Buy Ratings on Eli Lilly Stock (LLY) as Q1 Earnings Loom

Eli Lilly (LLY) is scheduled to release its Q1 earnings on May 1, and analysts continue to stay positive, holding onto Buy ...

Health on MSN1d

How and Where To Get Zepbound

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

24/7 Wall St. on MSN1d

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

3d

Is Eli Lilly Stock a Buy?

Given the potential opportunities in the sector, should investors buy Eli Lilly stock? Here's where the company and its stock ...

4d

Eli Lilly Positioned To Dominate Obesity Market With Oral Option, Analyst Initiates With Confidence

Eli Lilly gains analyst support after Phase 3 success. Bullish forecasts for obesity dominance and key earnings are set for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results